Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UMAC | Common Stock | Purchase | $100K | +65.8K | +124.35% | $1.52 | 119K | Oct 30, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UMAC | Warrants | Purchase | $100K | +65.8K | $1.52 | 65.8K | Oct 30, 2024 | Common Stock | 65.8K | $1.99 | Direct | F2 |
Id | Content |
---|---|
F1 | On October 29, 2024, the Issuer and the Reporting Person entered into a Securities Purchase Agreement (the "SPA"), pursuant to which the Reporting Person purchased 65,789 units, each unit consisting of one share of common stock and one warrant, from the Issuer in a private placement in reliance upon the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933 and Rule 506 promulgated thereunder. The transaction contemplated by the SPA closed on October 30, 2024 (the "Closing Date"). |
F2 | The warrants may not be exercised for 180 days after the Closing Date, so the Reporting Person is not deemed to be the beneficial owner of the underlying shares of common stock. The warrants contain beneficial ownership limitations preventing the Reporting Person from owning in excess of 4.99% or 9.99% of outstanding shares of common stock at any given time and, subject to shareholder approval, 19.99% of all current outstanding common stock currently outstanding or such lesser percentage required by the NYSE American without first obtaining stockholder approval in accordance with the NYSE American rules. |